Dr. Reddy's Laboratories reports 21% rise in Q4 consolidated net profit

10 May 2025 Evaluate

Dr. Reddy's Laboratories has reported results for fourth quarter (Q4) and year ended March 31, 2025.

The company has reported 16.03% rise in its net profit at Rs 1,200.70 crore for the quarter under review as compared to Rs 1,034.80 crore for the same quarter in the previous year. The total income of the company increased by 12.41% at Rs 5,977.30 crore for Q4FY25 as compared Rs 5,317.50 crore for the corresponding quarter previous year.

On consolidated basis, the company has reported 21.14% rise in its net profit at Rs 1,586.70 crore for fourth quarter ended March 31, 2025 as compared to Rs 1,309.80 crore for the same quarter in the previous year. The total income of the company increased by 23.79% at Rs 9,050.50 crore for Q4FY25 as compared Rs 7,311.30 crore for the corresponding quarter previous year. 

For the year ended March 31, 2025, the company has reported 23.20% rise in its net profit at Rs 5,349.40 crore as compared to Rs 4,342 crore for the previous year. The total income of the company increased by 18.54% at Rs 24,118.80 crore for year under review as compared to Rs 20,346.10 crore for year ended March 31, 2024.

For the year ended March 31, 2025, on the consolidated basis, the company has reported 2.64% rise in its net profit at Rs 5,725.20 crore as compared to Rs 5,577.90 crore for the previous year. The total income of the company increased by 16.73% at Rs 33,741.20 crore for year under review as compared to Rs 28,905.40 crore for year ended March 31, 2024.

Dr. Reddys Lab Share Price

1274.50 -2.50 (-0.20%)
05-Dec-2025 15:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.50
Dr. Reddys Lab 1274.50
Cipla 1520.00
Zydus Lifesciences 930.75
Lupin 2098.10
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×